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The role of FDG-PET/TC in the surgical approach of malignant 
pleural mesothelioma
Lequaglie, Cosimo1 Giudice, Gabriella1 Brega Massone, Pierpaolo2 
Della Morte, Aniello1 
1 Centro Riferimento Oncologico Regionale, Rionero in Vulture PZ, 
Italy 2 S. Rita Clinic, Milano, Italy 
Background: Approximately 20-30% of patients undergoing explor-
ative thoracotomy because of the inaccurate imaging used for staging 
in malignant pleural mesothelioma (MPM). FDG-PET/TC scan could 
help in preoperative staging, in operative evaluation and in postopera-
tive follow-up in MPM. 
Methods: Data from patients with pathologically proven, previously 
untreated, MPM was obtained from a prospective database. All patients 
underwent FDG-PET/TC scan. Patients were clinically staged using 
IMIG staging system. Operative selection criteria were: ps 0-1, cStage 
I-II, epithelial histology, predictive postoperative FEV1>1.0 L and 
resectable lung perfusion <50%, PaO2>65 mmHg, PaCO2<45 mmHg, 
ejection fraction >40%. Videothoracoscopy for diagnosis and for 
pleurodesis was made in all the cases. 
Fifty-ﬁve potentially EPP submitted patients (range age of 31-70 years) 
were observed between 1999 and 2006. Median PET SUV prior sur-
gery in the primary tumor was 6.8 (range 4-16). 
The same surgeon team operated 33 patients with MPM (21 male - 12 
female), with one only thoracotomic approach in 30 cases, 20 right-
sided lesions and 13 left-sided. 
Twenty-nine patients underwent EPP, 3 exploratory thoracotomies 
without resection for chest wall or inferior vena cava invasion, and 1 
laparoscopy for peritoneal metastases. All T4 or M1 cases were de-
tected by FDG-PET/TC preoperative scan. 
Pericardial (n=26) and diaphragmatic (n=29) defects were repaired 
by PTFE. Twenty-six patients had epithelioid subtype, 3 sarcomatous 
and 4 biphasics. Sixteen tumors were pStage I-II, 12 pStage III and 4 
pStage IV. 
Results: Of the 55 patients who had both FDG-PET/TC and surgical 
procedure only 4 had unresectable tumors. FDG-PET/TC correctly 
identiﬁed 1 unresectable tumor for proven peritoneal metastases. 
The follow-up study reported a sensibility of 95% with a diagnostic ac-
curacy of 92% regarding the local recurrences or distant metastases. 
The analysis correlation in patients with high and low SUV and epithe-
lioid and non-epithelioid histotype showed a better prognosis in both 
low SUV and epithelioid tumor. 
Conclusions: FDG-PET/TC appears to give a good support in staging 
and prognosis in MPM. Furthermore, a systematic use of PET scan 
could be prevent the recurrence of MPM in follow-up period in EPP 
submitted patients.
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Background: Malignant pleural mesothelioma (PM) is a highly 
aggressive tumour; occupational exposure to asbestos is the most com-
mon cause of this cancer. Prognosis is often severe, although occasion-
ally it is possible to observe survival times (ST) longer than two years. 
We do not know exactly whether and to what extent some variables, 
such as gender, age at diagnosis, cigarette smoking, histology, and oc-
cupational exposure, correlate with prognosis. 
Aim of this study was to show the differences between long and short 
survivors according to these variables. 
Methods: We retrospectively studied a series of 281 patients (234 
men and 47 women) affected by PM consecutively diagnosed in “illa 
Scassi” Hospital (Genoa, Italy) from 1994 to 2003 and subsequently 
deceased; live status was followed up to 2006, 30th June. Cases were 
systematically recorded by the regional population-based mesothelioma 
registry (COR Liguria), following inclusion criteria standardized by the 
national mesothelioma registry (RENAM). Mean age at diagnosis was 
68,6 and 70,6 among men and women, respectively, and difference was 
not statistically signiﬁcant (n.s.). Cell morphology was ascertained to 
be epitheliod in 74% of patients, sarcomatoid in 10%, biphasic in 8% 
and unspeciﬁed in 8%. Median overall survival was 12 and 14 months 
for men and women, respectively (n.s.). On the basis of ST, patients 
were classiﬁed into short (ST < 12 months) and long survivors (ST ≥ 24 
months), and a remaining group with intermediate ST (between 12 and 
23 months). According to this categorisation, 142 patients resulted to 
be short survivors (50%), 93 intermediate survivors (33%) and 48 long 
survivors (17%). The distribution by gender, age at diagnosis, histol-
ogy, cigarette smoking and occupational exposure within these groups 
has been investigated by performing ANOVA analysis on continuous 
variables and Chi square test on categorical ones. 
Results: No statistically signiﬁcant difference in survival experi-
ence was detected between men and women. Among women, age at 
diagnosis, cigarette smoking, histology and occupational exposure 
had no correlation to survival. Among men, younger age at diagnosis 
was associated with a better survival, as mean age was 70 years old 
among short survivors and 66 years old among long survivors (p=0.03). 
Subjects with epitheliod PM showed a better survival when compared 
to other morphologies (p=0.54, n.s.). Deﬁnite occupational exposure 
(versus probable or non occupational) was moderately related to a bet-
ter survival. Cigarette smoking had no correlation with survival.
Conclusions: From this large series of MPM patients, a sub-group of 
long survivors (ST ≥ 24 months) was identiﬁed. This subgroup with a 
better prognosis, with respect to shorter survivors, showed a younger 
age at diagnosis and a larger proportion of epitheloid MPM and of deﬁ-
nitely occupationally asbestos exposed cases. The analysis of the role 
of different therapies, as well as other prognostic factors, on survival 
has been planned.
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Surgical Resection for Oral Tongue Cancer Pulmonary Metastases, 
a Good Choice?
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Background: The lung is the most common distant metastasis site 
from oral tongue cancer (OTC). However, there have been no reports 
on surgical resection results for pulmonary OTC metastases. The aim 
of this study was to evaluate surgical resection for OTC pulmonary 
metastases efﬁcacy. 
Methods: Between 1977 and 2003, 23 OTC patients who developed 
1 to 3 pulmonary metastases underwent metastasectomy. The clinico-
pathologic features and long-term outcomes were examined. 
Results: The 14 men and 9 women had a median age at the time of pul-
monary metastasectomy of 56 (range; 28-72 years). All 23 patients had 
advanced squamous cell OTC with regional lymph node involvement 
or subsequent regional lymph node metastasis. The median tumor-free 
interval after the initial OTC treatment was 17 months (range: 1-165 
months). Five patients had pneumonectomy, three bilobectomy, 13 
lobectomy, and two wedge resection. Two patients underwent a second 
pulmonary metastasectomy. One patient continues to survive, without 
recurrence at 229 months right now. Twenty-two patients developed 
systemic metastases. The interval to systemic metastasis recurrence 
after pulmonary resection ranged from 1 to 17 months (median, 3.5 
months) and 21 died of OTC at 9.5 months median (range: 1-26 
months) after metastasectomy. One patient was alive with disease at 24 
months after metastasectomy but was lost to follow-up.
Conclusions: Most patients who had OTC pulmonary metastasectomy 
died of the disease within two years. Even for patients with a solitary 
metastasis, surgical resection for OTC pulmonary metastases is not a 
recommended treatment option.
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Background: Soluble mesothelin related proteins (SMRP) have been 
reported as being potential markers for the detection, staging and 
monitoring of treatment of malignant pleural mesothelioma (MPM). In 
order to evaluate the diagnostic accuracy, i.e. sensitivity and speciﬁcity 
of a new ELISA test, we investigated SMRP serum concentrations in 
patients with MPM, primary lung cancer and benign asbestos diseases, 
with a particular focus on differential diagnosis. 
Methods: The study population consisted of 100 newly diagnosed 
MPM patients. They were compared to 75 patients with severe forms 
of asbestosis and 139 patients suffering from untreated primary lung 
cancer. In addition, 29 MPM patient with tumor relapse or progres-
sion after initial therapy were included. SMRP serum concentrations 
were measured by using the newly developed ELISA kit Mesomark™ 
(Fujirebio Diagnostics, Malvern, USA distributed by CIS bio GmbH, 
Berlin, Germany). Statistical analyses (Mann-Whitney U-Test, ROC 
analysis) were performed with SPSS 14.0 (Chicago, Illinois, USA).
Results: SMRP concentrations were found to be signiﬁcantly higher 
in patients suffering from MPM in comparison to benign asbestos dis-
eases (p<0.001) or primary lung cancer (p<0.001). The median values 
(range) were 1.4 (0.2-31.0) nM, 0.9 (0.1-3.3) nM and 0.8 (0-6.0) nM 
respectively. The highest SMRP concentrations were found in patients 
with the epithelial subtype of MPM. However, this was not signiﬁ-
cantly different from the serum concentrations of the sarcomatoid and 
the biphasic subtypes. SMRP tended to increase with the tumour stages 
of MPM. 
At a cutoff value of 1.6 nM SMRP reached a sensitivity of 42% with a 
speciﬁcity of 95% for benign asbestos diseases. Youden index revealed 
an optimal cutoff value of 1.35 nM resulting in a sensitivity of 53% and 
a speciﬁcity of 88%. However, SMRP were also increased in 12.9% 
(cut-off 1.6 nM) or 19.9% (cutoff 1.35nM) of lung cancer patients. 
Receiver operator characteristics (ROC) curves resulted in an area 
under curve (AUC) of 0.72 (95%CI:0.66-0.79) for the discrimination 
between MPM and non-MPM patients (lung cancer and asbestosis). In 
the 29 MPM patients with relapse/progression after an initial therapy, 
SMRP levels were found to be signiﬁcantly higher (Median: 4.2 (0.2-
51.0) nM; p<0.001) compared to the 100 MPM patients without prior 
treatment.
Conclusion: SMRP serum concentration might be an useful measure 
in the diagnostic characterisation of MPM and for the differentiation 
between MPM, benign asbestosis and lung cancer patients. In addition, 
our results indicate that SMRP might be useful in treatment monitoring 
and follow-up. 
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Predictors of “long term” survival following surgical treatment of 
malignant pleural effusion
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Objective: To investigate prognostic factors following surgical pallia-
tion of malignant pleural effusion (MPE).
Method: We reviewed 280 consecutive patients [109 male, median age 
60 years (range 26 - 89)] undergoing 312 surgical procedures for pallia-
tion of MPE over 72 months. The commonest malignancies were breast 
(29%), malignant pleural mesothelioma (MPM) (25%), lung (12%), 
ovary (9%) and adenocarcinoma of unknown primary (5%). There 
